Home  >  Products  >  EBAG9 (estrogen receptor binding site associated, antigen, 9) Blocking Peptide (the C terminal of EBAG9)(100ug)
EBAG9 (estrogen receptor binding site associated, antigen, 9) Blocking Peptide (the C terminal of EBAG9)(100ug)

EBAG9 (estrogen receptor binding site associated, antigen, 9) Blocking Peptide (the C terminal of EBAG9)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-EBAG9 Antibody (ARP59868_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP59868
Size: 100ug
Weight: 24kDa
Gene: 9166
Format: Lyophilized powder
Target: This gene was identified as an estrogen-responsive gene. Regulation of transcription by estrogen is mediated by estrogen receptor which binds to the estrogen-responsive element (ERE) found in the 5'-flanking region of this gene. The encoded protein is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. Two transcript variants differing in the 5' UTR, but encoding the same protein, have been identified for this gene.
Alternative names: EB9; PDAF; RCAS1
See Full Product Listings >